116 filings
Page 5 of 6
8-K
kjaqx
17 Jul 18
Cara Therapeutics Announces Proposed Offering of Common Stock
5:24pm
8-K
g7ukx341r6dd4zlamhub
27 Jun 18
Cara Therapeutics Reports PositiveTop-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery
4:06pm
8-K
khxfe7 i0fnbwll54
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
59u4alic3w 0gm55w5u
23 May 18
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million
8:30am
8-K
0kfu58t4mhehw7270
23 May 18
Entry into a Material Definitive Agreement
6:06am
8-K
7k94l
9 May 18
Cara Therapeutics Reports First Quarter 2018 Financial Results
4:10pm
8-K
r4tf9tez9xcr4j7g
15 Mar 18
Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
ofomtb5 a0e
12 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
mrjgumfh9esh
2 Nov 17
Cara Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
8-K
fbd814b4
4 Aug 17
Departure of Directors or Certain Officers
12:00am
8-K
qeno09v d6h37yfq
3 Aug 17
Cara Therapeutics Reports Second Quarter 2017 Financial Results
12:00am
8-K
xn5v1car fysq
22 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
smvkw07byp4a cqqu6t
4 May 17
Cara Therapeutics Reports First Quarter 2017 Financial Results
12:00am
8-K
jg7t4
3 Apr 17
Cara Therapeutics Announces Proposed Offering of Common Stock
12:00am
8-K
zo7kut32a1 s8anec
28 Mar 17
Cara Therapeutics Announces PositiveTop-Line Data
12:00am
8-K
0kzkp4nzrtes0qr2ys
9 Mar 17
Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
qttza6p7vzzxl
3 Nov 16
Cara Therapeutics Reports Third Quarter 2016 Financial Results
12:00am
8-K
dg9k9l v7va6yqetg90
4 Aug 16
Cara Therapeutics Reports Second Quarter 2016 Financial Results
12:00am
8-K
hb32gi
16 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ts48v42pnbtxo874 0a2
5 May 16
Cara Therapeutics Reports First Quarter 2016 Financial Results
12:00am